会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Method of uniformizing dna fragment contents and subtraction method
    • dna片段内容均匀化和减法方法
    • US20050175997A1
    • 2005-08-11
    • US10481228
    • 2002-06-19
    • Yuichi OnoToshio Imai
    • Yuichi OnoToshio Imai
    • C12Q1/68
    • C12Q1/6809C12Q2531/113C12Q2525/191C12Q2525/131
    • A method of normalizing contents of DNA fragments in a sample among respective DNA fragments, comprising: preparing DNA fragments in which adaptors each comprising an oligodeoxyribonucleotide are attached to both ends of each DNA fragment in the sample to form restriction enzyme recognition sites that do not exist in the DNA fragments in the sample, and at least a part between the restriction enzyme recognition sites at both ends, including the restriction enzyme recognition sites, is double-stranded; denaturing the prepared double-stranded DNA fragments; hybridizing the denatured DNA fragments under a condition that a part of the DNA fragments remains single-stranded; cleaving the hybridized double-stranded DNA fragments with a restriction enzyme having a cleavage site exclusively in the adaptors; and performing PCR using the obtained DNA fragments as templates and using a primer having a nucleotide sequence complementary to a nucleotide sequence of the adaptors before the cleavage; and a subtraction method comprising performing normalization by the method.
    • 使各DNA片段中的样品中DNA片段的含量正常化的方法,包括:制备DNA片段,其中每个包含寡脱氧核糖核苷酸的衔接子连接到样品中每个DNA片段的两端,以形成不存在的限制酶识别位点 在样品中的DNA片段中,两端的限制酶识别位点(包括限制酶识别位点)之间的至少一部分是双链的; 使制备的双链DNA片段变性; 在一部分DNA片段保持单链的条件下使变性DNA片段杂交; 用具有切割位点的限制酶切割杂交的双链DNA片段,仅在适配器中; 并使用所获得的DNA片段作为模板并使用具有与切割前的衔接子的核苷酸序列互补的核苷酸序列的引物进行PCR; 以及减法方法,包括通过该方法执行归一化。
    • 9. 发明申请
    • Method and apparatus for producing metal by electrolysis of molton salt
    • 通过电解钼矿盐生产金属的方法和设备
    • US20090211916A1
    • 2009-08-27
    • US11631364
    • 2005-06-27
    • Masanori YamaguchiYuichi OnoSusumu KosemuraEiji Nishimura
    • Masanori YamaguchiYuichi OnoSusumu KosemuraEiji Nishimura
    • C25C3/00C25C7/00
    • C25C7/007C25C3/00C25C7/08
    • A process for production of a metal includes a step of filling a metal chloride in an electrolysis vessel having positive and negative electrodes, a step of heating and fusing the metal chloride to make an electrolytic bath, and a step of electrolyzing the electrolytic bath to deposit metal on the negative electrode in a solid state. In addition, in an apparatus for production of a metal in which a metal chloride is filled in an electrolysis vessel having positive and negative electrodes, the metal chloride is heated and molten to make an electrolytic bath and the electrolytic bath is electrolyzed to deposit the metal on the negative electrode in a solid state, the electrolytic bath is divided into an electrolysis chamber and a dissolution chamber by a dividing wall, the positive electrode is arranged in the electrolysis chamber, the negative electrode is arranged to enable orbital movement in a circle through the electrolysis chamber and dissolution chamber, and the metal deposited on the negative electrode in the electrolysis chamber is separated and recovered in the dissolution chamber.
    • 金属的制造方法包括在具有正极和负极的电解容器中填充金属氯化物的步骤,对金属氯化物进行加热和熔融以形成电解槽的步骤,以及电解槽沉积步骤 金属在负极上固态。 另外,在具有正极和负极的电解容器中填充有金属氯化物的金属的制造装置中,对金属氯化物进行加热熔融,形成电解槽,电解槽被电解以沉积金属 在固态的负极上,通过分隔壁将电解槽分为电解室和溶解室,正极配置在电解室中,负极配置成能够以圆周方式轨道运动 电解室和溶解室,并且沉积在电解室中的负极上的金属在溶解室中分离回收。
    • 10. 发明申请
    • Lrp4/Corin DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKERS
    • Lrp4 / Corin DOPAMINERGIC神经元增殖型细胞标志物
    • US20080280301A1
    • 2008-11-13
    • US12110111
    • 2008-04-25
    • Yuichi OnoYasuko NakagawaYoshimasa Sakamoto
    • Yuichi OnoYasuko NakagawaYoshimasa Sakamoto
    • C12Q1/68
    • C12Q1/6883C12Q2600/158
    • In neuron transplantation therapy, in terms of safety, it is preferable to use a cell population consisting only of a desired type of cells, and to use postmitotic neurons in consideration to avoid the risk of tumorigenesis. Moreover, greater therapeutic effects would be expected through the use of earlier progenitor cells in consideration of post-transplantation viability, proper network formation ability, and such.According to the present invention, Lrp4, a gene that is specifically expressed in dopaminergic neuron proliferative progenitor cells prior to cell cycle exit, was identified. The use of Lrp4 expression in cells as an index allows for the isolation. of cells suitable for transplantation therapy of neurodegenerative diseases such as Parkinson's disease in terms of safety, survival rate, and network formation ability.
    • 在神经元移植治疗中,在安全性方面,优选使用仅由期望类型的细胞组成的细胞群,并考虑使用神经元神经元以避免肿瘤发生的风险。 此外,考虑到移植后的生存力,适当的网络形成能力等,通过使用较早的祖细胞可以预期更大的治疗效果。 根据本发明,鉴定了在细胞周期退出之前在多巴胺能神经元增殖祖细胞中特异性表达的基因Lrp4。 在细胞中使用Lrp4表达作为指标,可以进行分离。 的细胞在安全性,存活率和网络形成能力方面适用于帕金森病等神经变性疾病的移植治疗。